- Home
- CYCC vs DHAI Comparison
CYCC vs DHAI Comparison
Compare CYCC & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- DHAI
- Stock Information
- Founded
- CYCC 1992
- DHAI 2007
- Country
- CYCC Malaysia
- DHAI United States
- Employees
- CYCC N/A
- DHAI N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- DHAI
- Sector
- CYCC Health Care
- DHAI
- Exchange
- CYCC Nasdaq
- DHAI NYSE
- Market Cap
- CYCC 61.2M
- DHAI 49.1M
- IPO Year
- CYCC N/A
- DHAI N/A
- Fundamental
- Price
- CYCC $1.63
- DHAI $0.23
- Analyst Decision
- CYCC
- DHAI
- Analyst Count
- CYCC 0
- DHAI 0
- Target Price
- CYCC N/A
- DHAI N/A
- AVG Volume (30 Days)
- CYCC 191.0K
- DHAI 1.2M
- Earning Date
- CYCC 05-15-2025
- DHAI 07-14-2025
- Dividend Yield
- CYCC 147.24%
- DHAI N/A
- EPS Growth
- CYCC N/A
- DHAI N/A
- EPS
- CYCC N/A
- DHAI N/A
- Revenue
- CYCC $14,000.00
- DHAI $69,573,000.00
- Revenue This Year
- CYCC $137.21
- DHAI N/A
- Revenue Next Year
- CYCC N/A
- DHAI N/A
- P/E Ratio
- CYCC N/A
- DHAI N/A
- Revenue Growth
- CYCC N/A
- DHAI 5.40
- 52 Week Low
- CYCC $1.36
- DHAI $0.12
- 52 Week High
- CYCC $49.34
- DHAI $3.67
- Technical
- Relative Strength Index (RSI)
- CYCC 32.89
- DHAI 52.42
- Support Level
- CYCC $1.36
- DHAI $0.21
- Resistance Level
- CYCC $1.94
- DHAI $0.28
- Average True Range (ATR)
- CYCC 0.43
- DHAI 0.03
- MACD
- CYCC -0.07
- DHAI 0.01
- Stochastic Oscillator
- CYCC 8.31
- DHAI 63.15
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.